Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”

(a) Change rates were calculated for each transect along the coastlines from 1985 to 2023; (b) Coastline change rates of the Caspian Sea based on the EPR and LRR. by Zihao Duan (17403792)

Subjects:

Change in average relative abundance of significantly different ASVs within distinct phyla classifications at all three time points for the three different treatments. by Charlotte H. Wang (8805353)

“…</b> For the control treatment, the change in average relative abundance of significantly different bacteria taxa in their relative phyla classifications generally decreased throughout consecutive time points. …”

Change in the levels of parental stressors or rewards between time point 1 and time point 2. by Ragnhild Bjørknes (4908577)

Subjects:

Average annual change, 95% confidence interval and significance for sum concentrations of different compound groups. by Matti Viluksela (321291)

The fold change of the main metabolites in CHA, CHM, and MHE rats with P values and VIP score. by Xue-Fei Liu (11156387)

Subjects:

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

IR-induced mutation profiles of DNA repair mutants significantly different from wild-type. by Bettina Meier (274833)

Subjects:

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

Bexarotene pretreatment significantly suppressed HBV and HDV infections in primary human hepatocytes (PHH). by Sameh A. Gad (12269979)

Cephalometric measurement points. by Lijuan Liu (136685)

Subjects:

Number of significant genes and fold change. by Gordon A. Barr (11163243)

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Changes in the melting points of each formulation of 0.1% FLU ophthalmic suspensions. by Tokio Obata (10783047)

Top significantly changed pathways based on their calculated enrichment factor and significance value. by Homica Arya (10954373)

“…<p>Top significantly changed pathways based on their calculated enrichment factor and significance value.…”

Averages of the fold decreases in the MICs of tested antibiotics in the presence of the tested compounds. by Safaa Abdel-Aal Mohamed Abdel-Karim (13175696)

Antibody response elicited by SARS-CoV-2 vaccines. by Chris Davis (647632)

Subjects: